⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbon Monoxide SCHEMBL11772530 | 1.00 | — | — | |
| Carbon Monoxide SCHEMBL8567941 | 1.00 | — | — | |
| Carbon Monoxide SCHEMBL1111 | 0.87 | — | — | |
| Carbon Monoxide SCHEMBL1331063 | 0.87 | — | — | |
| Carbon Monoxide SCHEMBL5306195 | 0.87 | — | — | |
| Carbon Monoxide SCHEMBL1376860 | 0.87 | — | — | |
| Carbon Monoxide SCHEMBL29355350 | 0.87 | — | — | |
| Carbon Monoxide SCHEMBL50187 | 0.75 | — | — | |
| Carbon Monoxide SCHEMBL8039507 | 0.75 | — | — | |
| Carbon Monoxide SCHEMBL8044682 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9439986-B2 | Tricarbonyl technetium-99m, rhenium-185/187, or rhenium-188 labeled cyclic RGD derivatives and uses thereof | BIO IMAGING KOREA CO., LTD. (KR) | 2016-09-13 | — | — | US | claimed |
| EP-2583966-B1 | TRICARBONYL TECHNETIUM-99M OR RHENIUM-188 LABEL RING RGD DERIVATIVE, A PREPARATION METHOD THEREOF, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE AS AN ACTIVE INGREDIENT FOR USE IN THE DIAGNOSIS OR TREATMENT OF ANGIOGENESIS-RELATED DISEASES | BIO IMAGING KOREA CO LTD (KR) | 2016-08-10 | — | — | EP | claimed |
| EP-2583966-A2 | TRICARBONYL TECHNETIUM-99M OR RHENIUM-188 LABEL RING RGD DERIVATIVE, A PREPARATION METHOD THEREOF, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVE AS AN ACTIVE INGREDIENT FOR USE IN THE DIAGNOSIS OR TREATMENT OF ANGIOGENESIS-RELATED DISEASES | SNU R & DB Foundation (KR) | 2013-04-24 | — | — | EP | claimed |
| US-20130064766-A1 | TRICARBONYL TECHNETIUM-99m OR RHENIUM-188 LABELED CYCLIC RGD DERIVATIVES, A PREPARATION METHOD THEREOF, AND A PHARMACEUTICAL COMPOSITION CONTAINING THE DERIVATIVES AS AN ACTIVE INGREDIENT FOR USE IN THE DIAGNOSIS OR TREATMENT OF ANGIOGENESIS-RELATED DISEASES | SNU R&DB FOUNDATION (KR) | 2013-03-14 | — | — | US | claimed |
| US-20090176968-A1 | Preparation of Triazole Containing Metal Chelating Agents | PAUL SCHERRER INSTITUT (CH) | 2009-07-09 | — | — | US | claimed |
| EP-2032590-A1 | TRIAZOLE CONTAINING METAL CHELATING AGENTS | PAUL SCHERRER INSTITUT (CH) | 2009-03-11 | — | — | EP | claimed |
| WO-2007147482-A1 | TRIAZOLE CONTAINING METAL CHELATING AGENTS | PAUL SCHERRER INSTITUT (CH) | 2007-12-27 | — | — | WO | claimed |
| EP-1013642-B1 | Chelating agents and the Technetium and Rhenium tricarbonyl complexes thereof | SCHERING AG (DE) | 2005-11-09 | — | — | EP | claimed |
| EP-1013642-A2 | Chelating agents and the technetium and rhenium tricarbonyl complexes thereof | Schering Aktiengesellschaft (DE) | 2000-06-28 | — | — | EP | claimed |
| EP-4373529-A1 | FIBROBLAST ACTIVATION PROTEIN INHIBITORS AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2024-05-29 | — | — | EP | disclosed |
| US-20240139352-A1 | HER2 BINDERS | GE Precision Healthcare LLC | 2024-05-02 | — | — | US | disclosed |
| US-20240115745-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 3B PHARMACEUTICALS GMBH (DE) | 2024-04-11 | — | — | US | disclosed |
| EP-4274836-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2023-11-15 | — | — | EP | disclosed |
| EP-4274835-A1 | COMPOUNDS COMPRISING A FIBROBLAST ACTIVATION PROTEIN LIGAND AND USE THEREOF | 3B Pharmaceuticals GmbH (DE) | 2023-11-15 | — | — | EP | disclosed |
| WO-2003086476-A1 | TECHNETIUM-LABELED ROTENONE DERIVATIVES, AND METHODS OF USE THEREOF | BIOSTREAM, INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| US-6488909-B1 | RADIODIAGNOSIS AND RADIOTHERAPY; COUPLED TO SUBSTANCES THAT ACCUMULATE IN THE DISEASED TISSUE | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-12-03 | — | — | US | disclosed |
| US-20020146846-A1 | Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment | ZURICH, UNIVERSITY OF (CH) | 2002-10-10 | — | — | US | disclosed |
| EP-1171468-A2 | METHOD FOR THE STABILIZATION OF CHIMERIC IMMUNOGLOBULINS OR IMMUNOGLOBULIN FRAGMENTS, AND STABILIZED ANTI-EGP-2 SCFV FRAGMENT | Universität Zürich (CH) | 2002-01-16 | — | — | EP | disclosed |
| WO-2000061635-A2 | METHOD FOR THE STABILIZATION OF CHIMERIC IMMUNOGLOBULINS OR IMMUNOGLOBULIN FRAGMENTS, AND STABILIZED ANTI-EGP-2 SCFV FRAGMENT | Universität Zürich (CH) | 2000-10-19 | — | — | WO | disclosed |
| EP-1013642-A2 | Chelating agents and the technetium and rhenium tricarbonyl complexes thereof | Schering Aktiengesellschaft (DE) | 2000-06-28 | — | — | EP | disclosed |